Aemetis Inc (NASDAQ:AMTX) has been assigned an average broker rating score of 2.50 (Hold) from the two brokers that cover the company, Zacks Investment Research reports. One analyst has rated the stock with a hold rating and one has issued a buy rating on the company.
Brokers have set a 1-year consensus target price of $2.00 for the company and are predicting that the company will post ($0.31) earnings per share for the current quarter, according to Zacks. Zacks has also assigned Aemetis an industry rank of 106 out of 255 based on the ratings given to its competitors.
A number of equities analysts have recently issued reports on the stock. Zacks Investment Research lowered shares of Aemetis from a “buy” rating to a “hold” rating in a research report on Monday. B. Riley set a $2.00 target price on shares of Aemetis and gave the stock a “hold” rating in a research report on Monday, August 13th.
Aemetis (NASDAQ:AMTX) last announced its quarterly earnings results on Thursday, August 9th. The specialty chemicals company reported ($0.27) EPS for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.34) by $0.07. The company had revenue of $45.03 million during the quarter, compared to analysts’ expectations of $42.51 million. On average, sell-side analysts anticipate that Aemetis will post -1.4 EPS for the current year.
Aemetis Company Profile
Aemetis, Inc operates as a renewable fuels and bio-chemicals company in North America and India. The company focuses on the acquisition, development, and commercialization of various technologies that replace traditional petroleum-based products by the conversion of ethanol and biodiesel plants into advanced bio refineries.
Further Reading: Growth Stocks, What They Are, What They Are Not
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Aemetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aemetis and related companies with MarketBeat.com's FREE daily email newsletter.